Auryxia
Active substance: tetraferric tricitrate decahydrate
TABLET, FILM COATED · TETRAFERRIC TRICITRATE DECAHYDRATE 210 mg/1
United StatesActive
Marketing holder: Akebia Therapeutics, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TETRAFERRIC TRICITRATE DECAHYDRATE · 210 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208e-8e55-7847-9a09-030c3c985668,01a12090-aaf8-713b-a25f-9bbbf1ce1b7f;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59922-631
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 59922-631 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59922-631 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59922-631 · Verified 2026-10-09 · open in source